Literature DB >> 3074990

Screening for congenital neural tube defects in a high-risk area: an epidemiological perspective.

D H Stone1, M J Smalls, K Rosenberg, J Womersley.   

Abstract

Data from the Glasgow Register of Congenital Malformations were used to investigate the extent of the recent decline in the prevalence of anencephaly and spina bifida, and the contribution of antenatal screening to it. Over the period 1974-85 inclusive, 303 pregnancies with an anencephalic foetus were diagnosed, representing an "adjusted" prevalence of 1.9 per 1000 total births, of which 179 (59%) were terminated following antenatal screening. There were 364 pregnancies with a spina bifida foetus representing an "adjusted" prevalence of 2.3 per 1000 total births, of which 84 (23%) were terminated. Over the study period, the "adjusted" prevalence of anencephaly fell by 50% while the birth prevalence fell by 89%; the "adjusted" prevalence of spina bifida fell by 38% while the birth prevalence fell by 76%. It was concluded that although the birth prevalence of both defects (particularly anencephaly) would have declined substantially in the absence of screening, the West of Scotland programme should continue.

Entities:  

Mesh:

Year:  1988        PMID: 3074990      PMCID: PMC1052737          DOI: 10.1136/jech.42.3.271

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  4 in total

Review 1.  The reduction of anencephalic and spina bifida births by maternal serum alphafetoprotein screening.

Authors:  M A Ferguson-Smith
Journal:  Br Med Bull       Date:  1983-10       Impact factor: 4.291

2.  Spina bifida and anencephaly in Scotland.

Authors:  V Carstairs; S Cole
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-03

3.  Spina bifida--a vanishing nightmare?

Authors:  J Lorber; A M Ward
Journal:  Arch Dis Child       Date:  1985-11       Impact factor: 3.791

4.  Can we afford screening for neural tube defects? The South Wales experience.

Authors:  B M Hibbard; C J Roberts; G H Elder; K T Evans; K M Laurence
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-26
  4 in total
  8 in total

1.  Prevalence of congenital anomalies in five British regions, 1991-99.

Authors:  J Rankin; S Pattenden; L Abramsky; P Boyd; H Jordan; D Stone; M Vrijheid; D Wellesley; H Dolk
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-09       Impact factor: 5.747

2.  Lead levels in domestic water supplies and neural tube defects in Glasgow.

Authors:  J E Macdonell; H Campbell; D H Stone
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

Review 3.  The Glasgow Register of Congenital Anomalies 1972-88: a critical review.

Authors:  D H Stone
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  Declining prevalence of hydrocephalus.

Authors:  D H Stone; J Womersley; T Sinclair; L Evans
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

5.  Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980-1986. EUROCAT Working Group.

Authors: 
Journal:  J Epidemiol Community Health       Date:  1991-03       Impact factor: 3.710

6.  Use of local neural tube defect registers to interpret national trends.

Authors:  K Hey; M O'Donnell; M Murphy; N Jones; B Botting
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

Review 7.  Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis.

Authors:  Callie A M Atta; Kirsten M Fiest; Alexandra D Frolkis; Nathalie Jette; Tamara Pringsheim; Christine St Germaine-Smith; Thilinie Rajapakse; Gilaad G Kaplan; Amy Metcalfe
Journal:  Am J Public Health       Date:  2015-11-12       Impact factor: 9.308

8.  Global prevalence of congenital anencephaly: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Reza Fatahian; Payam Mohammadi; Adibeh Rahmani; Niloofar Darvishi; Mona Keivan; Shamarina Shohaimi; Masoud Mohammadi
Journal:  Reprod Health       Date:  2022-10-17       Impact factor: 3.355

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.